Jhoti Harren 4
4 · Astex Pharmaceuticals, Inc · Filed Mar 15, 2012
Insider Transaction Report
Form 4
Jhoti Harren
DirectorPresident
Transactions
- Exercise/Conversion
Common Stock
2012-03-13$0.78/sh+16,084$12,546→ 52,384 total - Exercise/Conversion
Common Stock
2012-03-13$0.84/sh+17,400$14,616→ 69,784 total - Exercise/Conversion
Employee Stock Option (Right to buy)
2012-03-13−16,084→ 0 totalExercise: $0.78From: 2011-07-20Exp: 2014-07-01→ Common Stock (16,084 underlying) - Exercise/Conversion
Employee Stock Option (Right to buy)
2012-03-13−17,400→ 8,792 totalExercise: $0.84From: 2011-07-20Exp: 2015-12-01→ Common Stock (17,400 underlying)